How To Determine The Prevalence Of Microalbuminuria
|
|
|
- Dulcie Mills
- 5 years ago
- Views:
Transcription
1 Research Journal of Pharmaceutical, Biological and Chemical Sciences Prevalence of Microalbuminuria in relation to HbA1c among known Type2 Diabetic Patients in Puducherry population Muraliswaran P 1 *, Aparna G 1, Kanagavalli P 1 and Srikanth S 2 1 Department of Biochemistry, Sri Venkateshwaraa Medical College Hospital & Research Centre, Ariyur, Pondicherry India. 2 Department of Community Medicine, Sri Venkateshwaraa Medical College Hospital & Research Centre, Ariyur, Pondicherry India. ABSTRACT Diabetes mellitus is the commonest metabolic disorder and has a high prevalence in India. Diabetic nephropathy is characterized by proteinuria and is the leading cause of end stage renal disease. The prevalence of microalbuminuria predicts progression to diabetic nephropathy. This cross sectional study was carried out in the diabetic clinic at SVMCH and RC. Sixty known Type 2 diabetic patients with age years of both genders were included in the study. Fasting, postprandial venous blood and morning urine sample was collected for analysis of blood glucose, HbA1c and microalbuminuria levels. Statistical analysis was done using SPSS version Pearson correlation and Chi square test was applied to observe association of microalbuminuria with different parameters. P-value < 0.05 was considered as statistically significant. Our study showed that about 70% of the patients had HbA1c >7% and 48% of the patients had Microalbuminuria ( 30mg/day). Almost 45% of the patients with HbA1c >7% had Microalbuminuria ( 30mg/day) which indicates persistent increase in glycated haemoglobin and microalbuminuria may be considered as risk factor in diabetic nephropathy. Therefore, regular screening for microalbuminuria and HbA1c testing should be done in diabetic patients as an early marker of renal risk factor. Keywords: Type 2 Diabetes Mellitus, Microalbuminuria, HbA1c, Risk Factor, Nephropathy. *Corresponding author January-March 2013 RJPBCS Volume 4 Issue 1 Page No. 458
2 INTRODUCTION Diabetes Mellitus is an important metabolic disorder worldwide and is characterized by variable degree of insulin resistance, impaired insulin secretion & increased glucose levels.[1] Overall prevalence of diabetes is expected to increase worldwide by 122% (from 135 million to 300 million people) between 1995 and 2025; 90% of these people will have type 2 Diabetes.[2] The glycated hemoglobin (HbA 1c ) assay is the most commonly used measure of chronic glycaemia, since its introduction more than 25 years ago.[3] HbA 1c levels in diabetes for a good control will be 6.5% and that of 7.5% will be of greater risk.[4] Proteinuria is a key feature of diabetic nephropathy, a strong predictor of progression towards end stage renal failure. Proteinuria independently associates with coronary heart disease in patients with diabetes and reflects not only renal impairment and a key pathogenic element of disease progression, but also more generalized vascular damage.[5] Normally microalbumin mg/day or µg/min in 24 hours urine collection is characterized as microalbuminuria and the patient with microalbuminuria are referred to have incipient nephropathy.[6] Microalbuminuria is defined as an increase in urine albumin excretion above normal, but which is not detectable by conventional dip-stick testing, whilst proteinuria represents an increase in urine albumin that is detectable by conventional dip-stick testing. HbA 1c levels are higher in diabetic patients who develop micro- and macroalbuminuria, and there is strong prospective evidence that poor blood glucose control contributes to the development of albuminuria. Open analysis of UKPDS data suggested that for a 1% reduction in HbA 1c, there significantly (HbA 1c %) in those whose albumin excretion reverted to normal, and HbA 1c was significantly higher than in those who remained microalbuminuric (HbA 1c 7.7%) or developed proteinuria (HbA 1c 8.9). [7] Allawi et al, Ko et al, Mather et al and Vijay et al. reported the prevalence of microalbuminuria among 600 type 2 diabetic patients in Chennai.[8] Huraib et al. carried out study relating prevalence of microalbuminuria with urine albumin to creatinine ratio.[9] Varghese et al. carried out study among type 2 diabetic people and found a positive correlation between microalbuminuria and HbA 1c but did not find any statistical difference between microalbuminuria and two sexes.[10] This study was undertaken to assess the HbA 1c and microalbumin levels and thereby to assess the correlation between HbA 1c and microalbuminuria, which is a risk factor and an early indicator of diabetic nephropathy in Type 2 diabetes patients. AIM AND OBJECTIVES 1. To estimate the HbA1c levels among known type 2 Diabetic patients and the prevalence of Microalbuminuria among them. 2. To correlate the Microalbuminuria with HbA1c levels in Diabetic patients January-March 2013 RJPBCS Volume 4 Issue 1 Page No. 459
3 MATERIALS AND METHODS This cross sectional study was done among 60 known Type 2 diabetic patients attending medicine out-patient department at SVMCH & RC, Pondicherry. Institutional Ethical Committee Clearance and written informed consent was obtained. Patients with duration of Diabetes of 5 years, age between years of either gender were included. Patients with systemic diseases like cardiovascular diseases, cerebrovascular diseases, urinary tract infection and type I diabetes mellitus was excluded from the study. Fasting and 2 hour postprandial venous blood samples were collected for estimation of blood glucose levels. The fasting blood sample with EDTA was used to estimate HbA 1c levels using Affinity Chromatography method. A morning urine sample was used for estimating the microalbumin levels by Immunoturbidity method. HbA 1c levels <7% were considered to be normal and microalbumin < mg/day were considered to be normal. STATISTICAL ANALYSIS Datas were analysed using SPSS version17.0. Pearson correlation coefficient was calculated to find the linear relation between Hb A 1c and microalbuminuria. Chi square test was also used to find out relationship between HbA 1c and microalbuminuria. P value was taken as significant at 5 percent confidence level (P<0.05). RESULTS Among 60 known diabetic patients 65% were males and 35% females (Figure1). Table 1 summarizes the baseline and laboratory parameters. The mean age was 54±12.7 years. The mean duration of diabetes was 7.2±5.8 years. The mean of HbA 1c was 8.5± 2.2 % and mean microalbumin was 26.3± 13.1 mg/day. Our study revealed that out of 60 diabetic patients 42 (70%)had HbA 1c 7% and 18(30%) had less than 7%. Microalbuminuria was found among 29 (48%) patients. Table 1: Baseline and laboratory parameters of the study groups (n= 60) Minimum Maximum Mean Standard Deviation Age FBS PPBS HbA 1c Microalbumin A positive correlation was found among 25(45%) diabetic patients with uncontrolled glycaemic status which is shown by HbA 1c 7% and microalbuminuria indicated by >30mg/day January-March 2013 RJPBCS Volume 4 Issue 1 Page No. 460
4 and this was evidenced by Pearson s correlation coefficient (r= ) and Chi square test. p<0.05 was considered statistically significant (Table2 & Figure2). Figure1 Gender distribution Female 35% Male 65% Table 2: Correlation between HbA 1c and Microalbumin levels Microalbumin HbA 1c 30mg/day (number of patients) >30mg/day (number of patients) 7% 13 5 >7% Figure 2: Correlation Coefficient between HbA 1c and Microalbumin January-March 2013 RJPBCS Volume 4 Issue 1 Page No. 461
5 DISCUSSION Diabetic nephropathy is one of the most serious long-term complications of diabetes mellitus. Various epidemiological studies and cross-sectional studies have reported many variations in prevalence of microalbuminuria. Vijay et al. reported a prevalence of 15.7% in 600 type 2 diabetic patients in Chennai. [8] Huraib et al reported a prevalence of 16.8% among 125 type 2 diabetic patients in Saudi Arabia. [9] Varghese et al. reported a prevalence of 36.3% in 1425 type 2 diabetic patients in Chennai. [10] The variation in the prevalence of microalbuminuria can be attributed to several factors such as difference in population, the definition of microalbuminuria, the methods of measurement of microalbuminuria and urine collection etc. Huraib et al. also used immunoturbidity method for the assessment of microalbuminuria[9] which is the same method followed in the present study. In our study among 60 known diabetic patients, the prevalence of microalbuminuria with high HbA1c which was estimated to be statistically significant with a correlation of 45% (p<0.05). We also found that all patients with uncontrolled glycaemia was found to have a positive correlation with microalbuminuria. Thus in our study the correlation was found to be greater than previous studies. CONCLUSION It was concluded that the prevalence of microalbuminuria in diabetic patients in this study was found to be as high as 45%, which needs of therapeutic and preventive measures. Being a developing country, there is a need of microalbuminuria and HbA 1c testing in both newly diagnosed as well as already diagnosed type 2 diabetic patients as an early marker of renal risk factor. The present study emphazises education about strict glycaemic control and testing for microalbuminuria which is an early indicator of diabetic nephropathy, mandatory for all type 2 diabetic patients. REFERENCES [1] Defronzo RA. Diabetes Rev 1997; 5:177. [2] King H, Aubert RE, Herman WH. Diabetes Care 1998; 21: [3] Nathan DM, Turgeon H, Regan S. Diabetologia 2007; 50, [4] journals/contents/27/suppl_1/s79.full. [5] De Cosmo S, Piras GP et al. Diabetologia 1997; 40: [6] Microalbuminuria collaborative study group, United Kingdom. BMJ 1993; 306: [7] Stratton IM, Adler Al, Neil HA et al. BMJ 2000; 321: [8] Vijay V, Snehalatha C, Ramachandran A, Viswanathan M. J Assoc Physicians India. 1994; 42: [9] Huraib S, Abu-Aisha H, Sulimani RA, Famuyiwa FO, Al-Wakeel J, Askar A, et al. Ann Saudi Med 1995; 15: [10] Varghese A, Deepa R, Rema M, Mohan V. Postgrad Med J 2001; 77: January-March 2013 RJPBCS Volume 4 Issue 1 Page No. 462
How To Know If You Have Microalbuminuria
3 PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY Dr Ashok S Goswami *, Dr Janardan V Bhatt**; Dr Hitesh Patel *** *Associate
Understanding diabetes Do the recent trials help?
Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.
Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.
Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years
Frequency of Microalbuminuria in Type 1 Diabetic Children
Original Article Iran J Pediatr Dec 2009; Vol 19 (No 4), Pp:404-408 Frequency of Microalbuminuria in Type 1 Diabetic Children Zahra Razavi*, MD; Hossein Emad Momtaz, MD; Somayeh Sahari 1. Department of
GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY*
71 GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* Ryuichi KIKKAWA** Asian Med. J. 44(2): 71 75, 2001 Abstract: Diabetic nephropathy is the most devastating complication of diabetes and is now the
Prevalence of microalbuminuria among sudanese type 2 diabetic patients at elmusbah center at ombadda - omdurman
IOSR Journal of Pharmacy ISSN: 2250-3013, www.iosrphr.org Volume 2 Issue 5 Sep-Oct. 2012 PP.51-55 Prevalence of microalbuminuria among sudanese type 2 diabetic patients at elmusbah center at ombadda -
Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus
Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Number 84 Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Summary Overview Clinical
Glycemic Control of Type 2 Diabetes Mellitus
Bahrain Medical Bulletin, Vol. 28, No. 3, September 2006 Glycemic Control of Type 2 Diabetes Mellitus Majeda Fikree* Baderuldeen Hanafi** Zahra Ali Hussain** Emad M Masuadi*** Objective: To determine the
THE IMPACT OF USING BLOOD SUGAR HOME MONITORING DEVICE TO CONTROL BLOOD SUGAR LEVEL IN DIABETIC PATIENTS
THE IMPACT OF USING BLOOD SUGAR HOME MONITORING DEVICE TO CONTROL BLOOD SUGAR LEVEL IN DIABETIC PATIENTS Alshammari S., *Al-Jameel N., Al-Johani H, Al-Qahtani A., Al-Hakbani A., Khan A. and Alfaraj S.
Using a Flow Sheet to Improve Performance in Treatment of Elderly Patients With Type 2 Diabetes
Special Series: AAFP Award-winning Research Papers Vol. 31, No. 5 331 Using a Flow Sheet to Improve Performance in Treatment of Elderly Patients With Type 2 Diabetes Gary Ruoff, MD; Lynn S. Gray, MD, MPH
A Study on The Prevalence of Cardiac Autonomic Neuropathy in Type-2 Diabetes in Eastern India
ORIGINAL ARTICLE JIACM 2010; 11(3): 190-4 A Study on The Prevalence of Cardiac Autonomic Neuropathy in Type-2 Diabetes in Eastern India Abstract AK Basu*, R Bandyopadhyay**, S Chakrabarti***, R Paul****,
In many diabetes units, people with type
Renal Microalbuminuria: Screening and management in type 2 diabetes Julia Arundale Introduction In many diabetes units, patients with type 1 or type 2 diabetes are screened for proteinuria. Screening for
Diabetic Nephropathy
Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal
PLAN OF RESEARCH. About. Degree of control Diabetics Mellitus in Ramadan months. Dr. Ali Mustafa Diploma F.M
PLAN OF RESEARCH About Degree of control Diabetics Mellitus in Ramadan months Dr. Somaya Algowder Consultant F.M Doctor In- charge Naim Health center By Dr. Amal Al Zawadi Specialist F.M 2005-2006 Dr.
Prevalence of Micro and Macrovascular Complications and their Risk Factors in Type-2 Diabetes Mellitus
44 Journal of the association of physicians of india vol 62 published on 1st of every month 1st june, 2014 review article Prevalence of Micro and Macrovascular Complications and their Risk Factors in Type-2
Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes
Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center
Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus
Melissa Meredith M.D. Diabetes mellitus is a group of metabolic diseases characterized by high blood glucose resulting from defects in insulin secretion, insulin action, or both Diabetes is a chronic,
Primary prevention of chronic kidney disease: managing diabetes mellitus to reduce the risk of progression to CKD
Primary prevention of chronic kidney disease: managing diabetes mellitus to reduce the risk of progression to CKD Date written: July 2012 Author: Kate Wiggins, Graeme Turner, David Johnson GUIDELINES We
Microalbuminuria: We are in the midst of an epidemic: the epidemic. So What s a Little Protein? Malcolm s diabetes. How much is too much?
Focus on CME at the University of Saskatchewan Microalbuminuria: So What s a Little Protein? By Judith T. Klassen, BSc, MD, FRCPC University of Saskatchewan Practical Management of Common Medical Problems
Prediction of Kidney Disease Progression in Patients with Diabetes
Prediction of Kidney Disease Progression in Patients with Diabetes John Arthur, MD, PhD Medical University of South Carolina SEKDC Meeting September 8, 2012 Objectives Understand the importance of predicting
Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study
Indian J Med Res 136, July 2012, pp 46-53 Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study Vijay Viswanathan, Priyanka Tilak
Managing diabetes in the post-guideline world. Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ)
Managing diabetes in the post-guideline world Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ) Overview Pathogenesis of T2DM Aims of treatment The place of glycaemic control Strategies to improve glycaemic
Renal Disease in Type 2 Diabetes Mellitus
Renal Disease in Type 2 Diabetes Mellitus 6th Collaborative DiGP/HSE/UCC Conference 25 th September 2013 Dr. Eoin O Sullivan Consultant Endocrinologist Bon Secours Hospital Cork Case 69 year old woman
Diabetes and the Kidneys
Diabetes and the Kidneys Aim(s) and objective(s) This guideline focuses on the detection, prevention, and management of kidney disease in people with diabetes. The management of end-stage renal disease
Tuberculosis And Diabetes. Dr. hanan abuelrus Prof.of internal medicine Assiut University
Tuberculosis And Diabetes Dr. hanan abuelrus Prof.of internal medicine Assiut University TUBERCULOSIS FACTS More than 9 million people fall sick with tuberculosis (TB) every year. Over 1.5 million die
How To Know If Low Protein Diet Is Beneficial For Kidney Health
Protein Intake and Diabetic Kidney Disease Robert C. Stanton Joslin Diabetes Center 1/Serum Creatinine Plot Low Protein Protects in Renal Ablation Model 24% Protein Diet 6% Protein Diet Right Nephrectomy
PROCEEDINGS DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT
DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT Diabetic nephropathy affects people with either type 1 or type 2 diabetes mellitus.
Diabetes Complications
Managing Diabetes: It s s Not Easy But It s s Worth It Presenter Disclosures W. Lee Ball, Jr., OD, FAAO (1) The following personal financial relationships with commercial interests relevant to this presentation
嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯
The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized
Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital
Research Article Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital *T. JANAGAN 1, R. KAVITHA 1, S. A. SRIDEVI
Improving drug prescription in elderly diabetic patients. FRANCESC FORMIGA Hospital Universitari de Bellvitge
Improving drug prescription in elderly diabetic patients FRANCESC FORMIGA Hospital Universitari de Bellvitge High prevalence, but also increases the incidence. The older the patients, the higher the percentages
Guidelines for the management of hypertension in patients with diabetes mellitus
Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes
How To Find Out If Diabetic Nephropathy Increases Blood Sugar
Evaluation of Serum Sialic Acid and Microalbuminuria in Diabetic Nephropathy D. A. Divija 1*, A. Rajeshwari 2, Aliya Nusrath 3 1 Tutor, Department of Biochemistry, HIMS, Hassan District, Karnataka, INDIA.
Albuminuria versus GFR as markers of diabetic CKD progression
Albuminuria versus GFR as markers of diabetic CKD progression KDIGO Controversies Conference: Diabetic Kidney Disease New Delhi, March 2012 Richard J MacIsaac PhD FRACP Director of Endocrinology & Diabetes,
& Microalbuminuria. Glycosilated Hemoglobin. Two key parameters to prevent late diabetic complicatons. Dr. Antuña de Alaíz
& Microalbuminuria Glycosilated Hemoglobin Two key parameters to prevent late diabetic complicatons Dr. Antuña de Alaíz Index Microalbuminuria Introduction... Importance of the diabetic nephropathy...
Mortality Associated with Diabetes
Mortality Associated with Diabetes A review paper prepared for the 7th Global Conference of Actuaries, New Delhi, 15-16 February, 2005 Dr. David Muiry, MB;BS, FIA, FASI [email protected] Introduction
ASSOCIATED FACTORS OF EJECTION FRACTION IN INSULIN-TREATED PATIENTS WITH TYPE 2 DIABETES
Rev. Med. Chir. Soc. Med. Nat., Iaşi 204 vol. 8, no. 4 INTERNAL MEDICINE - PEDIATRICS ORIGINAL PAPERS ASSOCIATED FACTORS OF EJECTION FRACTION IN INSULIN-TREATED PATIENTS WITH TYPE 2 DIABETES Gina Botnariu
Personalized Therapy Algorithms for Type 2 Diabetes: A Phenotypization-based Approach
Personalized Therapy Algorithms for Type 2 Diabetes: A Phenotypization-based Approach Riccardo Candido on behalf of the Personalized Therapy AMD Study Group Diabetes Canter A.S.S. 1 Triestina, Italy BACKGROUND
ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes
ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,
Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.
Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused
Scottish Diabetes Survey 2013. Scottish Diabetes Survey Monitoring Group
Scottish Diabetes Survey 2013 Scottish Diabetes Survey Monitoring Group Contents Contents... 2 Foreword... 4 Executive Summary... 6 Prevalence... 8 Undiagnosed diabetes... 18 Duration of Diabetes... 18
EFFECT OF INCREASING DURATION OF DIABETES MELLITUS TYPE 2 ON GLYCATED HEMOGLOBIN AND INSULIN SENSITIVITY
EFFECT OF INCREASING DURATION OF DIABETES MELLITUS TYPE 2 ON GLYCATED HEMOGLOBIN AND INSULIN SENSITIVITY Dr. Meena Verma*, Dr.Sangeeta Paneri*, Preetha Badi* & Dr. P.G. Raman** Department of Biochemistry*
Guideline for Microalbuminuria Screening
East Lancashire Diabetes Network Guideline for Microalbuminuria Screening Produced by: Task and Finish Group, Clinical Standards Group Produced: August 2006 Approved by: East Lancashire Diabetes Network
Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks
Background: Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks Final Background and Scope November 19, 2015 The Centers for Disease Control
G:\ CDM\BHCIG Diabetes Pathway FINAL September 05.doc 1
G:\ CDM\BHCIG Diabetes Pathway FINAL September 05.doc 1 BHCiG: TYPE 2 DIABETES MANAGEMENT PATHWAY MODEL INTRODUCTION What is the aim of the model? To improve the capacity of primary care health practitioners
DIABETES A chronic, debilitating and often deadly disease A global epidemic Diabetes in Africa
DIABETES A chronic, debilitating and often deadly disease Diabetes is a chronic condition that arises when the pancreas does not produce enough insulin, or when the body cannot effectively use the insulin
Statins and Risk for Diabetes Mellitus. Background
Statins and Risk for Diabetes Mellitus Kevin C. Maki, PhD, FNLA Midwest Center for Metabolic & Cardiovascular Research and DePaul University, Chicago, IL 1 Background In 2012 the US Food and Drug Administration
InDependent Diabetes Trust
InDependent Diabetes Trust Kidneys and Diabetes Updated July 2015 Registered Company Number 3148360 Registered Charity No 1058284 Contents Introduction Healthy Kidneys Kidney disease and diabetes The use
Epidemiology of Diabetic Kidney Disease
Epidemiology of Diabetic Kidney Disease Anne T. Reutens, MBBS, PhD, FRACP a,b, * KEYWORDS Diabetes Prevalence Incidence Microalbuminuria Macroalbuminuria End-stage renal disease KEY POINTS Diabetic kidney
TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU
TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU Objectives: 1. To discuss epidemiology and presentation
DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE DRUGS IN DIABETIC PATIENTS WITH CKD
WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Elhami et al. SJIF Impact Factor 5.210 Volume 4, Issue 11, 1159-1166 Research Article ISSN 2278 4357 DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE
Department Of Biochemistry. Subject: Diabetes Mellitus. Supervisor: Dr.Hazim Allawi & Dr.Omar Akram Prepared by : Shahad Ismael. 2 nd stage.
Department Of Biochemistry Subject: Diabetes Mellitus Supervisor: Dr.Hazim Allawi & Dr.Omar Akram Prepared by : Shahad Ismael. 2 nd stage. Diabetes mellitus : Type 1 & Type 2 What is diabestes mellitus?
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type
Preetha selva et al. / International Journal of Phytopharmacology. 6(1), 2015, 42-46. International Journal of Phytopharmacology
International Journal of Phytopharmacology Journal homepage: www.onlineijp.com 42 e- ISSN 0975 9328 Print ISSN 2229 7472 IJP A CLINICAL STUDY TO EVALUATE THE EFFECT OF TOPICAL TAZAROTENE IN THE TREATMENT
I. Research Proposal. 1. Background
Sample CFDR Research Proposal I. Research Proposal 1. Background Diabetes has been described as the the perfect epidemic afflicting an estimated 104 million people worldwide (1). By 2010, this figure is
A Fuzzy Logic Based Model for Life Insurance Underwriting When Insurer Is Diabetic
European Journal of Applied Sciences 4 (5): 196-202, 2012 ISSN 2079-2077 IDOSI Publications, 2012 DOI: 10.5829/idosi.ejas.2012.4.5.2027 A Fuzzy Logic Based Model for Life Insurance Underwriting When Insurer
Deakin Research Online
Deakin Research Online This is the published version: Cameron, Adrian J., Shaw, J.E. and Zimmet, P.Z. 2003, Diabetes, in Diabetes and kidney disease : time to act, nternational Diabetes Federation, Brussels,
Self-Monitoring Of Blood Glucose (SMBG)
Self-Monitoring Of Blood Glucose (SMBG) Aim(s) and objective(s) It is important is to ensure that people with Diabetes are given the opportunity to self monitor their blood glucose appropriately as an
Risk factors and complications of type 2 diabetes in Asians
Risk factors and complications of type 2 diabetes in Asians Rajbharan Yadav, Pramil Tiwari* and Ethiraj Dhanaraj Department of Pharmacy Practice National Institute of Pharmaceutical Education and Research
Albuminuria as a Marker of the Risk of Developing Type 2 Diabetes in Non- Diabetic Aboriginal Australians
Albuminuria as a Marker of the Risk of Developing Type 2 Diabetes in Non- Diabetic Aboriginal Australians Zhiqiang Wang 1 and Wendy E Hoy 1 Centre for Chronic Disease, Department of Medicine, Central Clinical
KDIGO THE GEORGE INSTITUTE FOR GLOBAL HEALTH. Antiocoagulation in diabetes and CKD Vlado Perkovic
THE GEORGE INSTITUTE FOR GLOBAL HEALTH Antiocoagulation in diabetes and CKD Vlado Perkovic Executive Director, George Institute Australia Professor of Medicine, University of Sydney Affiliated with the
Insulin or GLP1 How to make this choice in Practice. Tara Kadis Lead Nurse - Diabetes & Endocrinology Mid Yorkshire Hospitals NHS Trust
Insulin or GLP1 How to make this choice in Practice Tara Kadis Lead Nurse - Diabetes & Endocrinology Mid Yorkshire Hospitals NHS Trust Workshop Over View Considerations/barriers to treatments in type 2
Insulin-Treated Diabetes. Guidelines for assessment of fitness to work as Cabin Crew
Insulin-Treated Diabetes Guidelines for assessment of fitness to work as Cabin Crew General Considerations As with all medical guidelines it is important that each individual case is assessed on its own
Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.
International Diabetes Federation Diabetes Background Information Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.
CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications
CHAPTER V DISCUSSION Background Diabetes mellitus is a chronic condition but people with diabetes can lead a normal life provided they keep their diabetes under control. Life style modifications (LSM)
David Shu, MD, FRCPC Endocrinology, Royal Columbian Hospital October 8 th, 2010
David Shu, MD, FRCPC Endocrinology, Royal Columbian Hospital October 8 th, 2010 Objectives At the end of the talk, the participants will be able to: 1. Identify the increasing prevalence of type 2 diabetes
Type 1 Diabetes ( Juvenile Diabetes)
Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.
The first injection of insulin was given on
EFFECTIVE USE OF INSULIN THERAPY IN TYPE 2 DIABETES * Bernard Zinman, MDCM ABSTRACT Type 2 diabetes is a progressive disease; an individual s ability to secrete insulin in increasing amounts to overcome
Peripheral Neuropathy among Elderly Diabetes in a Tertiary Center, Malaysia
64 Peripheral Neuropathy among Elderly Diabetes in a Tertiary Center, Malaysia Azidah A.K., Hasniza H., Lili Husniati Y * Department of Family Medicine, School of Medical Sciences, Universiti Sains Malaysia,
Statistics of Type 2 Diabetes
Statistics of Type 2 Diabetes Of the 17 million Americans with diabetes, 90 percent to 95 percent have type 2 diabetes. Of these, half are unaware they have the disease. People with type 2 diabetes often
Chapter 23. Composition and Properties of Urine
Chapter 23 Composition and Properties of Urine Composition and Properties of Urine urinalysis the examination of the physical and chemical properties of urine appearance - clear, almost colorless to deep
Jill Malcolm, Karen Moir
Evaluation of Fife- DICE: Type 2 diabetes insulin conversion Article points 1. Fife-DICE is an insulin conversion group education programme. 2. People with greater than 7.5% on maximum oral therapy are
Position Statement Diabetic Nephropathy American Diabetes Association
Information obtained from the American Diabetes Association 2002 by the American Diabetes Association, Inc. Publication Date January 2002 in Diabetes Care 25:S85-S89, 2002 Edited by the Nephrology Department,
The Economic Impact and Cost-Effectiveness of Glucose Monitoring
The Economic Impact and Cost-Effectiveness of Glucose Monitoring William H. Herman, MD, MPH Stefan S. Fajans/GlaxoSmithKline Professor of Diabetes Professor of Internal Medicine and Epidemiology University
Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007
Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering
Cardiovascular Disease in Diabetes
Cardiovascular Disease in Diabetes Where Do We Stand in 2012? David M. Kendall, MD Distinguished Medical Fellow Lilly Diabetes Associate Professor of Medicine University of MInnesota Disclosure - Duality
Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy
Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy Judith Long, MD,RWJCS Perelman School of Medicine Philadelphia Veteran Affairs Medical Center Background Objective Overview Methods
CASE B1. Newly Diagnosed T2DM in Patient with Prior MI
Newly Diagnosed T2DM in Patient with Prior MI 1 Our case involves a gentleman with acute myocardial infarction who is newly discovered to have type 2 diabetes. 2 One question is whether anti-hyperglycemic
Calculating the stage of Renal Disease
Calculating the stage of Renal Disease When the Refresh Template/Check Labs button is depressed, the box next to MDRD, will be automatically checked. In order to use this in the calculation of the stage
